Viewing Study NCT01163032

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:40 PM
Ignite Modification Date: 2026-05-23 @ 10:02 AM
Study NCT ID: NCT01163032
Status: COMPLETED
Last Update Posted: 2014-10-16
First Post: 2010-07-02
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
Sponsor: Vanda Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-24-Hour Sleep-Wake Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Blindness View
None Eye Diseases View
None Nap Disorders View
None Circadian Rhythm Disorders View
None Sleep disorders View
None Circadian Rhythm Sleep Disorders View
None Dyssomnias View
None Nervous System Diseases View